• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2050年放射肿瘤学将会是什么样子?审视欧洲及其他地区不断变化的专业格局。

What will radiation oncology look like in 2050? A look at a changing professional landscape in Europe and beyond.

作者信息

Baumann Michael, Ebert Nadja, Kurth Ina, Bacchus Carol, Overgaard Jens

机构信息

German Cancer Research Center (DKFZ), Heidelberg, Germany.

OncoRay-National Center for Radiation Research in Oncology, Medical Faculty and University Hospital Carl Gustav Carus, Technische Universität Dresden, Germany.

出版信息

Mol Oncol. 2020 Jul;14(7):1577-1585. doi: 10.1002/1878-0261.12731. Epub 2020 Jun 30.

DOI:10.1002/1878-0261.12731
PMID:32463984
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7332208/
Abstract

The number of newly diagnosed cancers per year is predicted to almost double in the next two decades worldwide, and it remains unclear if and when this alarming trend will level off or even reverse. As such, cancer is very likely to continue to pose a major threat to human health. Radiation oncology is an indispensable pillar of cancer treatment and a well-developed discipline. Nevertheless, key trends in cancer research and care, including improved primary prevention, early detection, integrated multidisciplinary approaches, personalized strategies at all levels of care, value-based assessments of healthcare systems, and global health perspectives, will all shape the future of radiation oncology. Broader scientific advances, such as rapid progress in digitization, automation, and in our biological understanding of cancer, as well as the wider societal view of healthcare systems will also influence radiation oncology and how it is practiced. To stimulate a proactive discussion on how to adapt and reshape our discipline, this review provides some predictions on what the role and practice of radiation oncology might look like in 30 years' time.

摘要

预计在未来二十年里,全球每年新确诊的癌症病例数量将几乎翻倍,目前尚不清楚这一惊人趋势是否以及何时会趋于平稳甚至逆转。因此,癌症很可能继续对人类健康构成重大威胁。放射肿瘤学是癌症治疗中不可或缺的支柱,也是一门成熟的学科。然而,癌症研究与治疗的关键趋势,包括改进一级预防、早期检测、综合多学科方法、各级护理中的个性化策略、基于价值的医疗系统评估以及全球健康视角,都将塑造放射肿瘤学的未来。更广泛的科学进展,如数字化、自动化方面的快速进步以及我们对癌症生物学理解的加深,还有社会对医疗系统更广泛的看法,也将影响放射肿瘤学及其实践方式。为了激发关于如何调整和重塑我们学科的积极讨论,本综述对三十年后放射肿瘤学的作用和实践可能是什么样做出了一些预测。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c51c/7332208/4519a4537bd9/MOL2-14-1577-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c51c/7332208/4519a4537bd9/MOL2-14-1577-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c51c/7332208/4519a4537bd9/MOL2-14-1577-g001.jpg

相似文献

1
What will radiation oncology look like in 2050? A look at a changing professional landscape in Europe and beyond.2050年放射肿瘤学将会是什么样子?审视欧洲及其他地区不断变化的专业格局。
Mol Oncol. 2020 Jul;14(7):1577-1585. doi: 10.1002/1878-0261.12731. Epub 2020 Jun 30.
2
Clinical cancer advances 2011: Annual Report on Progress Against Cancer from the American Society of Clinical Oncology.临床肿瘤进展 2011:美国临床肿瘤学会癌症进展年度报告。
J Clin Oncol. 2012 Jan 1;30(1):88-109. doi: 10.1200/JCO.2011.40.1919. Epub 2011 Dec 5.
3
Personalized oncology: recent advances and future challenges.个性化肿瘤学:最新进展与未来挑战。
Metabolism. 2013 Jan;62 Suppl 1:S11-4. doi: 10.1016/j.metabol.2012.08.016. Epub 2012 Sep 19.
4
Cancer Control in Central and Eastern Europe: Current Situation and Recommendations for Improvement.中东欧地区的癌症控制:现状与改进建议
Oncologist. 2016 Oct;21(10):1183-1190. doi: 10.1634/theoncologist.2016-0137. Epub 2016 Jul 8.
5
Multidisciplinary training of cancer specialists in Europe.欧洲癌症专科医生的多学科培训。
Eur J Cancer. 2017 Sep;83:1-8. doi: 10.1016/j.ejca.2017.05.043. Epub 2017 Jul 10.
6
How Advances in Imaging Will Affect Precision Radiation Oncology.影像学进展将如何影响精准放射肿瘤学。
Int J Radiat Oncol Biol Phys. 2018 Jun 1;101(2):292-298. doi: 10.1016/j.ijrobp.2018.01.047. Epub 2018 Jan 31.
7
[Continuing medical education in radiation oncology].[放射肿瘤学中的继续医学教育]
Cancer Radiother. 2012 Sep;16(5-6):392-7. doi: 10.1016/j.canrad.2012.07.182. Epub 2012 Aug 24.
8
Clinical Cancer Advances 2013: Annual Report on Progress Against Cancer from the American Society of Clinical Oncology.临床肿瘤进展 2013:美国临床肿瘤学会癌症进展年度报告。
J Clin Oncol. 2014 Jan 10;32(2):129-60. doi: 10.1200/JCO.2013.53.7076. Epub 2013 Dec 10.
9
Tuberculosis结核病
10
ESTRO 2012 strategy meeting: vision for radiation oncology.ESTRO 2012 战略会议:放射肿瘤学愿景。
Radiother Oncol. 2012 Apr;103(1):99-102. doi: 10.1016/j.radonc.2012.03.010. Epub 2012 Apr 3.

引用本文的文献

1
The impact of digital tools and the expected digital transformation in radiotherapy on Dutch radiation therapists (RTTs).数字工具的影响以及荷兰放射治疗师(RTTs)预期的放射治疗数字化转型。
Tech Innov Patient Support Radiat Oncol. 2025 Jun 4;34:100319. doi: 10.1016/j.tipsro.2025.100319. eCollection 2025 Jun.
2
Detection of radiosensitive subpopulations with Raman microspectroscopy.利用拉曼光谱检测放射敏感亚群
Front Oncol. 2025 Feb 27;15:1470431. doi: 10.3389/fonc.2025.1470431. eCollection 2025.
3
Precision Metrics: A Narrative Review on Unlocking the Power of KPIs in Radiology for Enhanced Precision Medicine.

本文引用的文献

1
Biomedical Research Goes Viral: Dangers and Opportunities.生物医药研究风靡全球:风险与机遇并存。
Cell. 2020 Jun 11;181(6):1189-1193. doi: 10.1016/j.cell.2020.05.014. Epub 2020 May 11.
2
Caring for patients with cancer in the COVID-19 era.在 COVID-19 时代照顾癌症患者。
Nat Med. 2020 May;26(5):665-671. doi: 10.1038/s41591-020-0874-8. Epub 2020 Apr 16.
3
Radiotherapy & Oncology during the COVID-19 pandemic.新冠疫情期间的放射治疗与肿瘤学
精准指标:关于释放放射学关键绩效指标以推动精准医学发展的叙述性综述
J Pers Med. 2024 Sep 10;14(9):963. doi: 10.3390/jpm14090963.
4
Antioxidants Hydroxytyrosol and Thioredoxin-Mimetic Peptide CB3 Protect Irradiated Normal Tissue Cells.抗氧化剂羟基酪醇和硫氧还蛋白模拟肽CB3可保护受辐射的正常组织细胞。
Antioxidants (Basel). 2024 Aug 7;13(8):961. doi: 10.3390/antiox13080961.
5
Optimizing Clinical Implementation of Hypofractionation: Comprehensive Evidence Synthesis and Practical Guidelines for Low- and Middle-Income Settings.优化大分割放疗的临床应用:低收入和中等收入地区的综合证据汇总与实用指南
Cancers (Basel). 2024 Jan 26;16(3):539. doi: 10.3390/cancers16030539.
6
Harnessing progress in radiotherapy for global cancer control.利用放疗进展助力全球癌症控制。
Nat Cancer. 2023 Sep;4(9):1228-1238. doi: 10.1038/s43018-023-00619-7. Epub 2023 Sep 25.
7
Evaluation of the ESMO-Magnitude of Clinical Benefit Scale version 1.1 (ESMO-MCBS v1.1) for adjuvant radiotherapy in breast cancer.评估 ESMO-MCBS v1.1 版(ESMO-MCBS v1.1)在乳腺癌辅助放疗中的应用。
ESMO Open. 2023 Jun;8(3):101206. doi: 10.1016/j.esmoop.2023.101206. Epub 2023 May 24.
8
Application of Gold Nanoparticles as Radiosensitizer for Metastatic Prostate Cancer Cell Lines.金纳米粒子作为转移性前列腺癌细胞系放射增敏剂的应用。
Int J Mol Sci. 2023 Feb 18;24(4):4122. doi: 10.3390/ijms24044122.
9
In Reply to Li et al.致李等人的回复
Adv Radiat Oncol. 2022 Jun 9;8(1):100997. doi: 10.1016/j.adro.2022.100997. eCollection 2023 Jan-Feb.
10
Teaching in radiation oncology: now and 2025-results of a focus group with medical students.放射肿瘤学教学:现在和 2025 年——医学学生焦点小组的结果。
Strahlenther Onkol. 2023 Apr;199(4):360-369. doi: 10.1007/s00066-022-01997-0. Epub 2022 Sep 5.
Radiother Oncol. 2020 May;146:221-222. doi: 10.1016/j.radonc.2020.04.043. Epub 2020 Apr 28.
4
Particle therapy in Europe.欧洲的粒子治疗
Mol Oncol. 2020 Jul;14(7):1492-1499. doi: 10.1002/1878-0261.12677. Epub 2020 Apr 22.
5
Radiotherapy-immunotherapy combinations - perspectives and challenges.放射治疗与免疫治疗联合——前景与挑战
Mol Oncol. 2020 Jul;14(7):1529-1537. doi: 10.1002/1878-0261.12658. Epub 2020 Mar 13.
6
Pan-cancer analysis of whole genomes.泛癌症全基因组分析。
Nature. 2020 Feb;578(7793):82-93. doi: 10.1038/s41586-020-1969-6. Epub 2020 Feb 5.
7
Pan-cancer analysis of whole genomes identifies driver rearrangements promoted by LINE-1 retrotransposition.全基因组泛癌症分析鉴定了由 LINE-1 反转录转座促进的驱动重排。
Nat Genet. 2020 Mar;52(3):306-319. doi: 10.1038/s41588-019-0562-0. Epub 2020 Feb 5.
8
Will immunotherapy really change radiotherapy?免疫疗法真的会改变放射治疗吗?
Lancet Oncol. 2019 Dec;20(12):1642-1644. doi: 10.1016/S1470-2045(19)30682-5. Epub 2019 Dec 2.
9
Characterisation and classification of oligometastatic disease: a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendation.寡转移疾病的特征描述和分类:欧洲放射肿瘤学会和欧洲癌症研究与治疗组织的共识建议。
Lancet Oncol. 2020 Jan;21(1):e18-e28. doi: 10.1016/S1470-2045(19)30718-1.
10
FLASH radiotherapy International Workshop.FLASH放射治疗国际研讨会
Radiother Oncol. 2019 Oct;139:1-3. doi: 10.1016/j.radonc.2019.07.020. Epub 2019 Aug 21.